Calbiotech

Executive Summary

Calbiotech is a U.S.-based contract development and manufacturing organization (CDMO) specializing in in vitro diagnostics (IVD), with a particular focus on immunoassays (ELISA/CLIA) and molecular diagnostics for infectious diseases. Founded in 1998 and headquartered in Spring Valley, California, the company offers end-to-end services from custom assay development to scalable manufacturing. It also markets a broad portfolio of research-use-only (RUO) ELISA kits for human and animal biomarkers. As a private, pre-clinical stage company with no disclosed funding or valuation, Calbiotech operates in the competitive CDMO space, serving diagnostic developers and researchers.

Upcoming Catalysts (preview)

• Q3 2026New CDMO contract for infectious disease diagnostic assay60% success
• Q4 2026Launch of a novel RUO ELISA kit for an emerging biomarker50% success
• Q1 2027Strategic partnership or distribution agreement for market expansion45% success